Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 5 min 47 sec ago

Lonza buys U.S. clinical manufacturing site from Shire

October 3, 2017 - 7:56pm
ZURICH (Reuters) - Lonza Group is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire PLC, the Swiss pharmaceutical ingredients group said on Tuesday without giving the purchase price.

Refugees' health problems in Greece mostly unmet: medical charity

October 3, 2017 - 7:28pm
ATHENS (Reuters) - Refugees and migrants in Greece receive little or no medical care for most health problems they face and fewer than half of those pregnant had access to maternal care, aid group Doctors of the World said on Tuesday.

Police search Merck's French plant in thyroid pill inquiry

October 3, 2017 - 7:16pm
LYON, France (Reuters) - French police searched German drugmaker Merck's plant in Lyon on Tuesday as part of an investigation into complaints by patients about changes to its thyroid drug Levothyrox, a company spokeswoman said.

RedHill Biopharma's bowel syndrome drug study meets main goal

October 3, 2017 - 5:41pm
(Reuters) - RedHill Biopharma Ltd said on Tuesday its drug to treat diarrhea-predominant irritable bowel syndrome (IBS-D) met the main goal in a mid-stage study, with patients showing improvement in stool consistency.

EU drugs head fears delays, health hazards as agency uprooted

October 3, 2017 - 4:51pm
LONDON (Reuters) - Access to new medicines and safety checks on existing treatments will be jeopardized if politicians pick a new home for Europe's London-based drugs regulator that is unacceptable to staff, its executive director told Reuters.

Oxford team to test universal flu vaccine in world first

October 3, 2017 - 1:40pm
LONDON (Reuters) - A seasonal flu vaccine that would be the first in the world to fight all types of the virus is to be tested in a two-year clinical trial involving more than 2,000 patients by researchers in Oxford.

Few U.S. hospitals can fully share electronic medical records

October 3, 2017 - 4:14am
(Reuters Health) - Less than one in three U.S. hospitals can find, send, and receive electronic medical records for patients who receive care somewhere else, a new study suggests.

Switching to e-cigarettes could save 6.6 million American smokers: researchers

October 3, 2017 - 4:09am
LONDON (Reuters) - Up to 6.6 million early deaths in America might be averted over 10 years if smokers switched to e-cigarettes, and the nicotine delivery devices should be adopted as part of an "endgame for cigarette smoking", researchers said on Monday.

Skipping breakfast tied to higher risk of hardening in arteries

October 3, 2017 - 3:45am
(Reuters Health) - People who skip breakfast may be more likely to develop atherosclerosis, or hardening of the arteries, than individuals who start each day with a hearty meal, a new study suggests.

FDA aims to speed up arrival of complex generic drugs

October 3, 2017 - 1:31am
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV's emergency EpiPen in an effort to address the rising cost of pharmaceuticals.

Fitness tracker games may help families get more exercise

October 3, 2017 - 12:05am
(Reuters Health) - When fitness trackers alone fail to get families moving enough, turning step counts into a competition might help people get more exercise, a small experiment suggests.

Shire sues Allergan in U.S. over dry eye drug

October 2, 2017 - 9:46pm
(Reuters) - Allergan Plc was sued on Monday by Shire Plc for allegedly scheming to block doctors from prescribing its new treatment for dry eye disease.

Exercise prevents elderly mobility problems, and the more the better

October 2, 2017 - 9:01pm
(Reuters Health) - Less than an extra hour a week of moderate exercise can make a big difference in helping older adults stay mobile and reduce their risk of developing major mobility problems, a U.S. study suggests.

U.S. FDA moves to smooth path for complex generic drugs

October 2, 2017 - 8:31pm
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market complex generic drugs such as Mylan NV's emergency EpiPen in an effort to address the rising cost of pharmaceuticals.

Americans want required food labels even if they don't read them

October 2, 2017 - 5:38pm
NEW YORK (Reuters) - A majority of Americans want the U.S. government to require nutrition labels on food packaging, including people who do not read them, according to a Reuters/Ipsos opinion poll released as the Trump administration delays tougher new requirements.

How we tick: U.S. 'body clock' scientists win Nobel medicine prize

October 2, 2017 - 5:07pm
STOCKHOLM/LONDON (Reuters) - U.S. scientists Jeffrey Hall, Michael Rosbash and Michael Young won the 2017 Nobel prize for medicine on Monday for unraveling molecular mechanisms that control our internal body clocks.

"Biological clock" scientists win 2017 Nobel Medicine Prize

October 2, 2017 - 3:33pm
STOCKHOLM (Reuters) - U.S.-born scientists Jeffrey Hall, Michael Rosbash and Michael Young won the 2017 Nobel Prize for Physiology or Medicine for their discoveries of molecular mechanisms controlling our biological clocks, the award-giving body said on Monday.

Belgian biotech Ablynx scores big hit with blood disease drug

October 2, 2017 - 1:38pm
(Reuters) - Belgian biotech company Ablynx reported resoundingly positive data for an experimental drug against a rare blood disorder on Monday, sending its market value above $1.1 billion.

Health experts zero in on camels to fight deadly MERS virus

October 1, 2017 - 10:36pm
GENEVA (Reuters) - The fight against the deadly Middle East Respiratory Syndrome (MERS), which has killed at least 722 people over the past five years, is honing in on its target: camels.

Pages